NeuroOne Medical Technologies Reported Earnings

NeuroOne Medical Technologies (NMTC) reported a loss of $0.28 per share on revenue of $1.97 million for the fiscal third quarter ended June 2026. . Revenue grew 16.33% on a year-over-year basis.

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs.